Prostate cancer: µ-crystallin CRYM protein inhibits tumour growth: Prostate cancer is one of the most commonly diagnosed forms of cancer in men and affects around 5,600 men in Austria each year. Hormone therapy is one of the core treatment strategies, but it is only effective for a certain period of time. It has been known […]
Read More… from Prostate cancer: µ-crystallin CRYM protein inhibits tumour growth